ImVitro
ImVitro is a Paris-based SaaS/medical-software company founded in 2019 that builds AI-driven computer-vision software to analyze IVF fertility imaging for fertility clinics and clinicians. It sells via subscription/licensing through direct enterprise sales and is pursuing U.S. expansion.
- Company typePrivate
- Founded2019
- HeadquartersParis, France
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
ImVitro firmographics
Firmographics- Name
- ImVitro
- Legal name
- ImVitro
- Website
- https://im-vitro.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- ImVitro is a Paris-based SaaS/medical-software company founded in 2019 that builds AI-driven computer-vision software to analyze IVF fertility imaging for fertility clinics and clinicians. It sells via subscription/licensing through direct enterprise sales and is pursuing U.S. expansion.
- Ownership category
- akta.pro rank
ImVitro industry classification
Industry- Product category
- Healthcare AI Software / IVF Imaging Software
- NAICS
- Software Publishers (513210)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- SaMD – Imaging & Signal Analysis (AI/ML) (HLACANAG)
- akta.pro secondary industries
- Medical Imaging AI (HDAAAEAH), Women’s Health & Fertility Therapeutics (Digital) (HLACANAK)
Keywords
Where ImVitro is headquartered
LocationHeadquarters
- HQ city
- Paris
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
ImVitro business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- Software licensing/subscription: AI-driven software sold or licensed to IVF fertility clinics as a tool to assist clinicians in fertility treatments. Revenue likely derives from software subscriptions or licensing fees to healthcare providers.
Go-to-market motion1 record
Distribution channels1 record
ImVitro product offering
Product offeringCore offering
ImVitro develops and sells an AI-driven SaaS software platform that applies computer vision to in vitro fertilization (IVF) imaging. The software analyzes fertility images to assist fertility clinics and clinicians in IVF treatment workflows, with the goal of improving clinical decision-making and treatment outcomes.
Differentiator
Problem solved
Functional benefit
Products and services
- AI-Driven IVF Fertility Imaging Software AI-powered software that applies computer vision to IVF fertility imaging to assist fertility clinics and clinicians in analyzing fertility images, supporting clinical decisions in IVF treatments such as embryo assessment and follicle counting.
Companies that use ImVitro
Customer profileSegments1 record
Ideal customer profiles1 record
ImVitro technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature1 record
ImVitro partnerships and signals
Strategic signalScale indicators1 record
ImVitro competitors and assessment
Company assessmentDirect peers
- AIVF: AIVF is an Israel- and U.S.-based company applying AI to IVF clinic workflows including embryo assessment and cycle optimization. It directly competes with ImVitro in AI software for fertility clinics, targeting the same customer base and use cases.
- Alife Health: Alife Health builds an AI platform for IVF clinics that supports embryo ranking, cycle decisions, and clinical workflow analytics. It is one of the most direct comparables to ImVitro in AI-driven IVF clinical-decision software.
- Future Fertility: Future Fertility provides AI-powered oocyte and egg quality assessment for fertility clinics. It overlaps directly with ImVitro's imaging-based AI approach in the IVF patient journey and serves the same clinician customer.
- Embryonics: Embryonics applies AI/computer vision to embryo selection in IVF. As a venture-backed startup in the same niche, it competes with ImVitro for clinic partnerships in AI embryo assessment.
Emerging players
- Presagen: Presagen develops AI for women's health and fertility imaging, including embryo and IVF-related applications. It overlaps with ImVitro in AI women's-health imaging but operates a broader platform across multiple fertility use cases.
- TMRW Life Sciences: TMRW Life Sciences provides automated cryostorage and digital specimen management for IVF clinics. While focused on storage rather than imaging, it is part of the same emerging digital-software stack modernizing IVF labs.
Broad incumbents
- Vitrolife: Vitrolife is an established global provider of IVF media, consumables, and lab solutions. As an incumbent in the IVF clinic stack, it is a comparable channel partner and a potential integrator or competitor for AI-driven IVF imaging software.
- Genea Biomedx: Genea Biomedx develops connected IVF lab devices and software platforms. Its emphasis on digitizing IVF lab workflows makes it an incumbent peer comparable to ImVitro's clinic-side software positioning.
- CooperSurgical: CooperSurgical is a large women's-health and fertility medical device company offering a wide portfolio of IVF products and services. It represents the broader incumbent space in which ImVitro's clinic-software offering competes for budget and integration.
- Ferring Pharmaceuticals: Ferring Pharmaceuticals is a global reproductive medicine company active in IVF therapeutics and fertility clinics. As a broad incumbent in the fertility ecosystem, it represents an important industry context and potential strategic partner for AI IVF software players like ImVitro.
Market position
Customer concentration
ImVitro financial estimates
Financial estimateRevenue estimate
Valuation estimate
ImVitro leadership team
Management profileNumber of profiles
Profiles2 records
ImVitro funding detail
Funding detailFunding overview
Funding rounds3 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ImVitro M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ImVitro
What does ImVitro do?
ImVitro develops and sells an AI-driven SaaS software platform that applies computer vision to in vitro fertilization (IVF) imaging. The software analyzes fertility images to assist fertility clinics and clinicians in IVF treatment workflows, with the goal of improving clinical decision-making and treatment outcomes.
Is ImVitro a public or private company?
ImVitro is a private company. It is classified as venture growth investor backed and is currently operating.
When was ImVitro founded?
ImVitro was founded in 2019. It employs 11 to 50 people.
Where is ImVitro based?
ImVitro is headquartered in Paris, France, in the Europe region.
How does ImVitro make money?
One revenue line is on record: software licensing/subscription.
Who are ImVitro's main competitors?
Direct peers on record are AIVF, Alife Health, Future Fertility and Embryonics. Emerging players are Presagen and TMRW Life Sciences. Broad incumbents are Vitrolife, Genea Biomedx, CooperSurgical and Ferring Pharmaceuticals.
Does ImVitro have an API?
No public API is recorded for ImVitro.
What industry is ImVitro in?
ImVitro's product category is Healthcare AI Software / IVF Imaging Software. Its primary akta.pro industry code is HLACANAG, SaMD – Imaging & Signal Analysis (AI/ML), with a secondary code of HDAAAEAH, Medical Imaging AI. Its NAICS code is 513210 and its SIC code is 7372.